Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding | 1.33% | $175.10M | $468.07B | 61.61% | 81 Outperform | |
| Roche Holding AG | 1.05% | $138.51M | CHF270.15B | 45.02% | 73 Outperform | |
| AstraZeneca | 1.02% | $133.58M | £220.54B | 29.01% | 80 Outperform | |
| HSBC Holdings | 1.00% | $131.89M | £204.52B | 49.59% | 80 Outperform | |
| Royal Bank Of Canada | 0.90% | $118.36M | $236.91B | 39.35% | 75 Outperform | |
| Shell (UK) | 0.88% | $115.57M | £151.07B | -1.97% | 73 Outperform | |
| Nestlé SA | 0.84% | $110.67M | CHF188.36B | 12.31% | 71 Outperform | |
| SAP SE | 0.72% | $95.16M | €237.28B | -15.64% | 66 Neutral | |
| Novartis | 0.71% | $93.85M | $270.27B | 41.15% | 80 Outperform | |
| LVMH Moet Hennessy Louis Vuitton | 0.67% | $87.90M | €312.82B | -1.45% | 78 Outperform |